Topics
-
Business Results Announcement for the Fiscal Year Ending March 31, 2020 (See Latest Financial Statements)
-
Updated : Sysmex Report 2019
-
Development of a Fully Automated Measurement Method for Soluble Immune Checkpoint Molecules (sPD-1, sPD-L1 and sCTLA-4)
-
Updated : Sysmex Sustainability Data Book 2019
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
-
Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”
Press Releases
- Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020 (PDF：374KB)
- Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2019, and Revision of Full-Year Financial Forecasts (PDF：228KB)
- Sysmex Wins Awards in 2019 Kinki Local Commendations for Innovations
-
Sysmex and OPTiM Reach a Basic Agreement on the Establishment of a Joint Venture to Accelerate the Commercialization of Digital Medicine to Support Next-Generation Healthcare and Diagnostics
-Aiming toward the Early-Stage Provision of Platforms and Applications Related to Digital Medicine- -
Industry, Government and Academia Jointly Establish a General Incorporated Association to Promote the Bioresource Business
-Jointly Established by Kobe University, the City of Kobe, the Foundation for Biomedical Research and Innovation at Kobe, and Sysmex-
